FadiKayaliMD

Oncology • Sarasota, FL

Physician

Join to view full profile

Dr. Kayali is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kayali's full profile

Already have an account?

Office
600 N Cattlemen Rd
Suite 200
Sarasota, FL 34232
Phone+1 941-377-9993

Fax+1 941-343-0026

Education & Training

University of Louisville School of MedicineFellowship, Hematology and Medical Oncology, 2007 - 2010
Trinity Health Oakland/Wayne State UniversityResidency, Internal Medicine, 2004 - 2007
St Petersburg Medical State AcademyClass of 1997

Certifications & Licensure

FL State Medical License 2010 - 2026
OK State Medical License 2011 - 2012
KY State Medical License 2007 - 2011
MI State Medical License 2004 - 2007
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Hospice and Palliative Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2014
CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013

Publications & Presentations

PubMed

38 citations
A phase I clinical trial of ruxolitinib in combination with nilotinib in chronic myeloid leukemia patients with molecular evidence of disease.
Kendra Sweet, Lori A. Hazlehurst, Eva Sahakian, John Powers, Lisa Nodzon
Leukemia Research. 2018-10-16
78 citations
Venous thromboembolism in patients hospitalized with nephrotic syndrome.
Fadi Kayali, Reiad Najjar, Firas Aswad, Fadi Matta, Paul D. Stein
The American Journal of Medicine. 2008-03-01
24 citations
Spiral computed tomography for the diagnosis of acute pulmonary embolism.
Paul D. Stein, Fadi Kayali, Russell D. Hull
Thrombosis and Haemostasis. 2007-10-01

Journal Articles

A Phase I Clinical Trial of Ruxolitinib in Combination with Nilotinib in Chronic Myeloid Leukemia Patients with Molecular Evidence of Disease
Kendra Sweet, Fadi Kayali, Javier Pinilla-Ibarz, Leukemia Research
A Phase I Clinical Trial of Ruxolitinib in Combination with Nilotinib in Chronic Myeloid Leukemia Patients with Molecular Evidence of Disease
Kendra Sweet, Fadi Kayali, Javier Pinilla-Ibarz, Leukemia Research

Authored Content

A Phase I Clinical Trial of Ruxolitinib in Combination with Nilotinib in Chronic Myeloid Leukemia Patients with Molecular Evidence of DiseaseOctober 2018

Other Languages

Russian, Arabic, Russian, Arabic